Esperion Therapeutics

Esperion is a pharmaceutical company with the only oral non-statins FDA approved to lower LDL-C and reduce the risk of MI and coronary revascularization in primary prevention and secondary prevention. Strong developing pipeline in renal, liver & oncology. recent development in PSC Primary Sclerosing Cholangitis.

Address

Ann Arbor
Michigan
United States
Visit website (opens in a new tab)
Loading